A systematic review of The role of C4d in The diagnosis of acute antibody-mediated rejection

Kidney International

Volumn 87, Issue 1, 2015, Pages 182-194

  Sapir Pichhadze, Ruth ^a,b,c   Curran, Simon P ^a   John, Rohan ^c   Tricco, Andrea C ^d   Uleryk, Elizabeth ^e   Laupacis, Andreas ^b,d   Tinckam, Kathryn ^a,c   Sis, Banu ^f   Beyene, Joseph ^b,g,h   Logan, Alexander G ^a,b,c   Kim, S Joseph ^a,b,c,i  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

^g HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^h MCMASTER UNIVERSITY   (Canada)

ⁱ ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Acute rejection; C4d; histocompatibility; kappa; kidney transplantation; sensitivity; specificity

Indexed keywords

COMPLEMENT COMPONENT C4D; ANTIBODY; COMPLEMENT C4D; COMPLEMENT COMPONENT C4B; PEPTIDE FRAGMENT;

ACUTE ANTIBODY MEDIATED REJECTION; ACUTE GRAFT REJECTION; ANTIBODY MEDIATED REJECTION; ARTICLE; CAPILLARITIS; DIAGNOSTIC TEST ACCURACY STUDY; DONOR SPECIFIC ANTIBODY ASSAY; GLOMERULITIS; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; MICROCIRCULATORY INFLAMMATION; PERITUBULAR CAPILLARITIS; PROTEIN FUNCTION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; ACUTE DISEASE; FLUORESCENT ANTIBODY TECHNIQUE; GRAFT REJECTION; IMMUNOLOGY; KIDNEY TRANSPLANTATION; PROGNOSIS;

ACUTE DISEASE; ANTIBODIES; COMPLEMENT C4B; FLUORESCENT ANTIBODY TECHNIQUE; GRAFT REJECTION; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY TRANSPLANTATION; PEPTIDE FRAGMENTS; PROGNOSIS;

EID: 84920273358     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.166     Document Type: Article

References (124)

1. Einecke G, Sis B, Reeve J et al. Antibody-mediated microcirculation injury is The major cause of late kidney transplant failure. Am J Transplant 2009; 9: 2520-2531.
2. Gaston RS, Cecka JM, Kasiske BL et al. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation 2010; 90: 68-74.
3. Hidalgo LG, Campbell PM, Sis B et al. De novo donor-specific antibody at The time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant 2009; 9: 2532-2541.
4. Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria-an addition to The Banff'97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708-714.
5. Gordis L. Epidemiology, 2nd edn WB Saunders: Philadelphia, PA, 2000.
6. Thompson ML. Assessing The diagnostic accuracy of a sequence of tests. Biostatistics 2003; 4: 341-351.
7. Zwirner J, Felber E, Herzog V et al. Classical pathway of complement activation in normal and diseased human glomeruli. Kidney Int 1989; 36: 1069-1077.
8. Feucht HE, Felber E, Gokel MJ et al. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol 1991; 86: 464-470.
9. Collins AB, Schneeberger EE, Pascual MA et al. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999; 10: 2208-2214.
10. Regele H, Exner M, Watschinger B et al. Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection. Nephrol Dial Transplant 2001; 16: 2058-2066.
11. Bohmig GA, Exner M, Habicht A et al. Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 2002; 13: 1091-1099.
12. Mauiyyedi S, Crespo M, Collins AB et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002; 13: 779-787.
13. Nickeleit V, Zeiler M, Gudat F et al. Detection of The complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol 2002; 13: 242-251.
14. Herzenberg AM, Gill JS, Djurdjev O et al. C4d deposition in acute rejection: an independent long-term prognostic factor. J Am Soc Nephrol 2002; 13: 234-241.
15. Ludovico-Martins H, Silva C, Teodoro WR et al. Analysis of different staining techniques for c4d detection in renal allograft biopsies. Transplant Proc 2009; 41: 862-865.
16. Troxell ML, Weintraub LA, Higgins JP et al. Comparison of C4d immunostaining methods in renal allograft biopsies. Clin J Am Soc Nephrol 2006; 1: 583-591.
17. Seemayer CA, Gaspert A, Nickeleit V et al. C4d staining of renal allograft biopsies: a comparative analysis of different staining techniques. Nephrol Dial Transplant 2007; 22: 568-576.
18. Nadasdy GM, Bott C, Cowden D et al. Comparative study for The detection of peritubular capillary C4d deposition in human renal allografts using different methodologies. Hum Pathol 2005; 36: 1178-1185.
19. Kats A, Whiting J, Ahmed A. Optimization of C4d for automated immunohistochemistry on formalin-fixed, paraffin-embedded tissue. Ann Clin Lab Sci 2010; 40: 197.
20. Phanomsri E-o Namwat N, Tangrassameeprasert R et al. Comparative study for The detection of C4d in paraffin-embedded renal allograft biopsies by immunohistochemical techniques. J Med Assoc Thai 2010; 93(Suppl 3): S61-S68.
21. Fior F, Nacchia F, Minicozzi A et al. Focal C4d staining in peritubular capillaries and kidney graft survival: results of a retrospective study. Transplant Proc 2010; 42: 1095-1097.
22. Magil AB, Tinckam KJ. Focal peritubular capillary C4d deposition in acute rejection. Nephrol Dial Transplant 2006; 21: 1382-1388.
23. Haririan A, Kiangkitiwan B, Kukuruga D et al. The impact of c4d pattern and donor-specific antibody on graft survival in recipients requiring indication renal allograft biopsy. Am J Transplant 2009; 9: 2758-2767.
24. Loupy A, Hill GS, Suberbielle C et al. Significance of minimal and focal C4d in stable DSA kidney transplant recipients. Am J Transplant 2010; 10: 125.
25. Tinckam K. Histocompatibility methods. Transpl Rev 2009; 23: 80-93.
26. Solez K, Colvin RB, Racusen LC et al. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007; 7: 518-526.
27. Gibson IW, Gwinner W, Brocker V et al. Peritubular capillaritis in renal allografts: prevalence, scoring system, reproducibility and clinicopathological correlates. Am J Transplant 2008; 8: 819-825.
28. Sis B, Jhangri GS, Riopel J et al. A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant 2012; 12: 1168-1179.
29. Haas M, Mirocha J. Early ultrastructural changes in renal allografts: correlation with antibody-mediated rejection and transplant glomerulopathy. Am J Transplant 2011; 11: 2123-2131.
30. Haas M. Pathology of C4d-negative antibody-mediated rejection in renal allografts. Curr Opin Organ Transplant 2013; 18: 319-326.
31. Joudeh A, Saliba KA, Topping KA et al. Pathologic basis of antibody-mediated organ transplant rejection: from pathogenesis to diagnosis. Curr Opin Organ Transplant 2013; 18: 478-485.
32. Feucht HE, Schneeberger H, Hillebrand G et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993; 43: 1333-1338.
33. Crespo M, Pascual M, Tolkoff-Rubin N et al. Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. Transplantation 2001; 71: 652-658.
34. Crary GS, Raissian Y, Gaston RC et al. Optimal cutoff point for immunoperoxidase detection of C4d in The renal allograft: results from a multicenter study. Transplantation 2010; 90: 1099-1105.
35. Herman J, Lerut E, Van Damme-Lombaerts R et al. Capillary deposition of complement C4d and C3d in pediatric renal allograft biopsies. Transplantation 2005; 79: 1435-1440.
36. Solez K, Axelsen RA, Benediktsson H et al. International standardization of criteria for The histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411-422.
37. Colvin RB, Cohen AH, Saiontz C et al. Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation. J Am Soc Nephrol 1997; 8: 1930-1941.
38. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723.
39. Trpkov K, Campbell P, Pazderka F et al. Pathologic features of acute renal allograft rejection associated with donor-specific antibody, analysis using The Banff grading schema. Transplantation 1996; 61: 1586-1592.
40. Sis B, Mengel M, Haas M et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464-471.
41. Solez K, Colvin RB, Racusen LC et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8: 753-760.
42. Solez K, Racusen LC. The Banff classification revisited. Kidney Int 2013; 83: 201-206.
43. Mengel M, Sis B, Haas M et al. Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant 2012; 12: 563-570.
44. Kedainis RL, Koch MJ, Brennan DC et al. Focal C4d + in renal allografts is associated with The presence of donor-specific antibodies and decreased allograft survival. Am J Transplant 2009; 9: 812-819.
45. Verghese P, Dunn T, Najafian B et al. The impact of C4d and microvascular inflammation before we knew them. Clin Transplant 2013; 27: 388-396.
46. Cheunsuchon B, Vongwiwatana A, Premasathian N et al. The prevalence of C4d-positive renal allografts in 134 consecutive biopsies in Thai patients. Transplant Proc 2009; 41: 3697-3700.
47. de Kort H, Willicombe M, Brookes P et al. Microcirculation inflammation associates with outcome in renal transplant patients with de novo donor-specific antibodies. Am J Transplant 2013; 13: 485-492.
48. Kikic Z, Regele H, Nordmeyer V et al. Significance of peritubular capillary, glomerular, and arteriolar C4d staining patterns in paraffin sections of early kidney transplant biopsies. Transplantation 2011; 91: 440-446.
49. Mengel M, Bogers J, Bosmans J-L et al. Incidence of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial. Am J Transplant 2005; 5: 1050-1056.
50. Ranjan P, Nada R, Jha V et al. The role of C4d immunostaining in The evaluation of The causes of renal allograft dysfunction. Nephrol Dial Transplant 2008; 23: 1735-1741.
51. Haas M, Sis B, Racusen LC et al. Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 2014; 14: 272-283.
52. Poduval RD, Kadambi PV, Josephson MA et al. Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection. Transplantation 2005; 79: 228-235.
53. Sund S, Hovig T, Reisaeter AV et al. Complement activation in early protocol kidney graft biopsies after living-donor transplantation. Transplantation 2003; 75: 1204-1213.
54. Bartel G, Wahrmann M, Exner M et al. In vitro detection of C4d-fixing HLA alloantibodies: associations with capillary C4d deposition in kidney allografts. Am J Transplant 2008; 8: 41-49.
55. Worthington JE, McEwen A, McWilliam LJ et al. Association between C4d staining in renal transplant biopsies, production of donor-specific HLA antibodies, and graft outcome. Transplantation 2007; 83: 398-403.
56. Koo DDH, Roberts ISD, Quiroga I et al. C4d deposition in early renal allograft protocol biopsies. Transplantation 2004; 78: 398-403.
57. Kraus ES, Parekh RS, Oberai P et al. Subclinical rejection in stable positive crossmatch kidney transplant patients: incidence and correlations. Am J Transplant 2009; 9: 1826-1834.
58. Loupy A, Hill GS, Suberbielle C et al. Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). Am J Transplant 2011; 11: 56-65.
59. Aiello FB, Furian L, Della Barbera M et al. Glomerulitis and endothelial cell enlargement in C4d + and C4d-acute rejections of renal transplant patients. Hum Pathol 2012; 43: 2157-2166.
60. Kayler LK, Kiss L, Sharma V et al. Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d. Transplantation 2008; 85: 813-820.
61. Lederer SR, Kluth-Pepper B, Schneeberger H et al. Impact of humoral alloreactivity early after transplantation on The long-term survival of renal allografts. Kidney Int 2001; 59: 334-341.
62. Brenner H, Gefeller O. Variation of sensitivity, specificity, likelihood ratios and predictive values with disease prevalence. Stat Med 1997; 16: 981-991.
63. Stegall MD, Chedid MF, Cornell LD. The role of complement in antibody-mediated rejection in kidney transplantation. Nat Rev Nephrol 2012; 8: 670-678.
64. Haas M, Montgomery RA, Segev DL et al. Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts. Am J Transplant 2007; 7: 576-585.
65. Loupy A, Suberbielle-Boissel C, Hill GS et al. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 2009; 9: 2561-2570.
66. Lefaucheur C, Loupy A, Vernerey D et al. Antibody-mediated vascular rejection of kidney allografts: a population-based study. Lancet 2013; 381: 313-319.
67. Haas M. Pathologic features of antibody-mediated rejection in renal allografts: an expanding spectrum. Curr Opin Nephrol Hypertens 2012; 21: 264-271.
68. Bagnasco S, Kraus E, Sis B. Diagnostic criteria for kidney transplant rejection: a call to action. Lancet 2013; 381: 1458.
69. Shimizu T, Ishida H, Shirakawa H et al. Clinicopathological analysis of acute vascular rejection cases after renal transplantation. Clin Transplant 2010; 24(Suppl 22): 22-26.
70. Messias NC, Eustace JA, Zachary AA et al. Cohort study of The prognostic significance of acute transplant glomerulitis in acutely rejecting renal allografts. Transplantation 2001; 72: 655-660.
71. Lefaucheur C, Nochy D, Hill GS et al. Determinants of poor graft outcome in patients with antibody-mediated acute rejection. Am J Transplant 2007; 7: 832-841.
72. Roberts DM, Jiang SH, Chadban SJ. The treatment of acute antibody-mediated rejection in kidney transplant recipients-a systematic review. Transplantation 2012; 94: 775-783.
73. Haas M, Rahman MH, Racusen LC et al. C4d and C3d staining in biopsies of ABO-and HLA-incompatible renal allografts: correlation with histologic findings. Am J Transplant 2006; 6: 1829-1840.
74. Setoguchi K, Ishida H, Shimmura H et al. Analysis of renal transplant protocol biopsies in ABO-incompatible kidney transplantation. Am J Transplant 2008; 8: 86-94.
75. Haas M, Segev DL, Racusen LC et al. C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts. J Am Soc Nephrol 2009; 20: 197-204.
76. Haas M. The significance of C4d staining with minimal histologic abnormalities. Curr Opin Organ Transplant 2010; 15: 21-27.
77. Park WD, Grande JP, Ninova D et al. Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury. Am J Transplant 2003; 3: 952-960.
78. Cornell LD. Renal allograft pathology in The sensitized patient. Curr Opin Organ Transplant 2013; 18: 327-336.
79. Cornell LD, Alexander MP, Stegall MD. Antibody-mediated injury in The renal allograft. Pathol Case Rev 2012; 17: 219-224.
80. Cohen D, Colvin RB, Daha MR et al. Pros and cons for C4d as a biomarker. Kidney Int 2012; 81: 628-639.
81. Gloor JM, Stegall MD. ABO incompatible kidney transplantation. Curr Opin Nephrol Hypertens 2007; 16: 529-534.
82. Colvin RB. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol 2007; 18: 1046-1056.
83. Baid-Agrawal S, Farris AB 3rd, Pascual M et al. Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy. Kidney Int 2011; 80: 879-885.
84. Husain S, Sis B. Advances in The understanding of transplant glomerulopathy. Am J Kidney Dis 2013; 62: 352-363.
85. Akalin E, Dinavahi R, Dikman S et al. Transplant glomerulopathy may occur in The absence of donor-specific antibody and C4d staining. Clin J Am Soc Nephrol 2007; 2: 1261-1267.
86. Al Aly Z, Yalamanchili P, Cortese C et al. C4d peritubular capillary staining in chronic allograft nephropathy and transplant glomerulopathy: an uncommon finding. Transpl Int 2005; 18: 800-805.
87. Batal I, Aggarwal N, Lunz J et al. Histologic grade of transplant glomerulitis (TGI) correlates with transplant glomerulopathy (TGP) and graft outcome independent of C4d status. Am J Transplant 2010; 10: 396.
88. Collins AB, Farris AB, Smith RN et al. Challenges in The diagnosis of chronic antibody mediated rejection due to loss of peritubular capillaries and low extent and transient nature of C4d deposition. Lab Invest 2009; 89: 301A-302A.
89. Colvin RB, Cornell LD. Renal transplant pathology: an update. Curr Diagn Pathol 2007; 13: 15-24.
90. Cornell LD, Gloor JD, Nasr SH et al. Chronic humoral rejection despite C5 inhibition after positive-crossmatch kidney transplantation (XMKTx). Am J Transplant 2010; 10: 125-126.
91. Cornell LD, Gloor JM, Raghavaiah S et al. Chronic antibody mediated histologic changes in positive-crossmatch kidney transplants (XMKTx) receiving early C5 blockade. Am J Transplant 2012; 12: 450.
92. Cosio FG, Gloor JM, Sethi S et al. Transplant glomerulopathy. Am J Transplant 2008; 8: 492-496.
93. Costa RM, Martul EV, Reboredo J et al. Transplant glomerulopathy and de novo thrombotic microangiopathy: different manifestations of humoral rejection. Nephrol Dial Transplant 2013; 28: i277-i278.
94. David DSR, Bringhenti RN, Ventura CG et al. Indication biopsies ten years after renal transplant frequently show antibody-mediated mechanisms of allograft injury. Am J Transplant 2012; 12: 489.
95. David-Neto E, Prado E, Beutel A et al. C4d-positive chronic rejection: a frequent entity with a poor outcome. Transplantation 2007; 84: 1391-1398.
96. De Kort H, Willicombe M, Brookes P et al. Microcirculation injury is predictive of graft loss in renal transplant patients with de novo donor-specific antibodies. Am J Transplant 2012; 12: 43.
97. Debiais C, Goujon JM, Quellard N et al. Glomerular C4d staining and chronic transplant glomerulopathy. Am J Transplant 2011; 11: 296.
98. Feucht HE, Mihatsch MJ. Diagnostic value of C4d in renal biopsies. Curr Opin Nephrol Hypertens 2005; 14: 592-598.
99. Haas M. Early ultrastructural abnormalities of transplant glomerulopathy (TG): Correlation with C4d-positive and C4d-negative antibody-mediated rejection (AMR) and subsequent development of overt TG. Lab Invest 2011; 91: 345A.
100. Issa N, Cosio FG, Gloor JM et al. Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels. Transplantation 2008; 86: 681-685.
101. John R, Konvalinka A, Tobar A et al. Determinants of long-term graft outcome in transplant glomerulopathy. Transplantation 2010; 90: 757-764.
102. Kieran N, Wang X, Perkins J et al. Combination of peritubular c4d and transplant glomerulopathy predicts late renal allograft failure. J Am Soc Nephrol 2009; 20: 2260-2268.
103. Miura M, Ogawa Y, Kubota KC et al. Donor-specific antibody in chronic rejection is associated with glomerulopathy, thickening of peritubular capillary basement membrane, but not C4d deposition. Clin Transplant 2007; 21: 8-12.
104. Nair R, Fraer M, Agrawal N et al. Acute transplant glomerulopathy is associated with antibody-mediated rejection and poor graft outcome. Transplant Proc 2010; 42: 3507-3512.
105. Najafian B, Leduc R, Gibson I et al. C4d is a strong predictor of graft survival in transplant glomerulopathy. Am J Transplant 2010; 10: 415.
106. Namba Y, Oka K, Moriyama T et al. Incidence of positive C4d deposition in long-term survival cases over 10 yr after renal transplantation. Clin Transplant 2006; 20(Suppl 15): 20-25.
107. Patri P, Muthukumar T, Iwasaki S et al. Transplant glomerulopathy-an analysis of 96 cases to determine The risk factors of allograft failure. Am J Transplant 2013; 13: 324-325.
108. Perkowska-Ptasinska A, Ciszek M, Chmura A et al. Transplant glomerulopathy: clinical and pathological correlations. Transplant Proc 2009; 41: 141-149.
109. Shimizu T, Ishida H, Shirakawa H et al. Clinicopathological analysis of transplant glomerulopathy cases. Clin Transplant 2009; 23(Suppl 20): 39-43.
110. Sijpkens YW, Joosten SA, Wong M-C et al. Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy. Kidney Int 2004; 65: 2409-2418.
111. Sis B, Campbell PM, Mueller T et al. Transplant glomerulopathy, late antibody-mediated rejection and The ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007; 7: 1743-1752.
112. Sun Q, Liu Z, Huang X et al. Transplant glomerulopathy is strongly correlated with antibody-mediated microcirculating injury: data from a comprehensive clinico-pathlogical evaluation. Am J Transplant 2010; 10: 51.
113. Vongwiwatana A, Gourishankar S, Campbell PM et al. Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy. Am J Transplant 2004; 4: 124-129.
114. Hayde N, Bao Y, Pullman J et al. The clinical and molecular significance of C4d staining patterns in renal allografts. Transplantation 2013; 95: 580-588.
115. Selman TJ, Khan KS, Mann CH. An evidence-based approach to test accuracy studies in gynecologic oncology: The 'STARD' checklist. Gynecol Oncol 2005; 96: 575-578.
116. Furness PN, Taub N. Convergence of European Renal Transplant Pathology Assessment Procedures P. International variation in The interpretation of renal transplant biopsies: report of The CERTPAP Project [published erratum appears in Kidney Int 2001; 60: 2429] Kidney Int 2001; 60: 1998-2012.
117. Mengel M, Chan S, Climenhaga J et al. Banff initiative for quality assurance in transplantation (BIFQUIT): Reproducibility of C4d immunohistochemistry in kidney allografts. Am J Transplant 2013; 13: 1235-1245.
118. Mengel M, Campbell P, Gebel H et al. Precision diagnostics in transplantation: from bench to bedside. Am J Transplant 2013; 13: 562-568.
119. de Vet HCW, Eisinga A, Riphagen II et al. Chapter 7: Searching for Studies. In: Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 0.4 (updated September 2008). The Cochrane Collaboration, 2008; www.cochrane.org: Birmingham UK.
120. Schueler S, Schuetz GM, Dewey M. The revised QUADAS-2 tool. Ann Intern Med 2012; 156: 323 author reply 323-324.
121. Whiting PF, Rutjes AW, Westwood ME et al. QUADAS-2: a revised tool for The quality assessment of diagnostic accuracy studies. Ann Intern Med 2011; 155: 529-536.
122. McGinn T, Wyer PC, Newman TB et al. Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic). CMAJ 2004; 171: 1369-1373.
123. Team RC. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria, 2013.
124. Altman DG. Systematic reviews of evaluations of prognostic variables. BMJ 2001; 323: 224-228.